This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
Lilly (LLY) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Lilly (LLY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
LLYPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
MediaAlpha (MAX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for MediaAlpha (MAX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MAXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Pagaya Technologies Ltd. (PGY) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Pagaya Technologies Ltd. (PGY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PGYPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Warby Parker (WRBY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
WRBYPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings
by Zacks Equity Research
The headline numbers for Zai Lab Limited (ZLAB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZLABPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Altice USA (ATUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Altice USA (ATUS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ATUSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Warner Bros. Discovery (WBD) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Warner Bros. Discovery (WBD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
WBDPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Insulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PODDPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
SharkNinja, Inc. (SN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for SharkNinja, Inc. (SN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SNPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
TEGNA (TGNA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for TEGNA (TGNA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
TGNAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Somnigroup International (SGI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Somnigroup International (SGI) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SGIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Xeris Biopharma (XERS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
XERSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Gogo (GOGO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Gogo (GOGO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GOGOPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
United Parks & Resorts (PRKS) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for United Parks & Resorts (PRKS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PRKSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Americold Realty Trust (COLD) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Americold Realty Trust (COLD) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
COLDPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Yeti (YETI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Yeti (YETI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
YETIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Peloton (PTON) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Peloton (PTON) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PTONPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
PRVAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, RXO (RXO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for RXO (RXO) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
RXOPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Immunocore (IMCR) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
IMCRPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Target Hospitality (TH) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Target Hospitality (TH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
THPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Cars.com (CARS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Cars.com (CARS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CARSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Tecnoglass (TGLS) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Tecnoglass (TGLS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TGLSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
XRAYPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ELANPositive Net Change
earnings earnings-estimates-revisions earnings-surprise